Baird Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,016
| Closed | -$239K | – | 1801 |
|
|
2024
Q2 | $239K | Sell |
2,016
-50
| -2% | -$5.94K | ﹤0.01% | 1623 |
|
|
2024
Q1 | $220K | Sell |
2,066
-4,536
| -69% | -$483K | ﹤0.01% | 1648 |
|
|
2023
Q4 | $657K | Sell |
6,602
-1,877
| -22% | -$187K | ﹤0.01% | 1272 |
|
|
2023
Q3 | $876K | Sell |
8,479
-1,533
| -15% | -$158K | ﹤0.01% | 1153 |
|
|
2023
Q2 | $1.22M | Buy |
10,012
+150
| +2% | +$18.2K | ﹤0.01% | 1054 |
|
|
2023
Q1 | $1.51M | Sell |
9,862
-2,856
| -22% | -$439K | ﹤0.01% | 976 |
|
|
2022
Q4 | $2.29M | Buy |
12,718
+1,006
| +9% | +$181K | 0.01% | 837 |
|
|
2022
Q3 | $1.39M | Buy |
11,712
+4,313
| +58% | +$510K | ﹤0.01% | 956 |
|
|
2022
Q2 | $1.06M | Buy |
7,399
+2,120
| +40% | +$303K | ﹤0.01% | 1063 |
|
|
2022
Q1 | $909K | Sell |
5,279
-1,109
| -17% | -$191K | ﹤0.01% | 1186 |
|
|
2021
Q4 | $1.62M | Sell |
6,388
-2,516
| -28% | -$639K | ﹤0.01% | 1012 |
|
|
2021
Q3 | $3.43M | Sell |
8,904
-1,318
| -13% | -$507K | 0.01% | 734 |
|
|
2021
Q2 | $2.4M | Buy |
10,222
+328
| +3% | +$77.1K | 0.01% | 843 |
|
|
2021
Q1 | $1.3M | Buy |
9,894
+7,683
| +347% | +$1.01M | ﹤0.01% | 1036 |
|
|
2020
Q4 | $231K | Buy |
+2,211
| New | +$231K | ﹤0.01% | 1462 |
|